{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:14Z","timestamp":1792783394923,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T00:00:00Z","timestamp":1455926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the national science and technology project","award":["2013GS500101-05"],"award-info":[{"award-number":["2013GS500101-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s13277-016-4981-6","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T16:15:16Z","timestamp":1455984916000},"page":"11057-11063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Roles of microRNA-124a and microRNA-30d in breast cancer patients with type 2 diabetes mellitus"],"prefix":"10.1007","volume":"37","author":[{"given":"Shu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Ji","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Guo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-E","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Lin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,20]]},"reference":[{"issue":"1","key":"4981_CR1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s12032-013-0788-0","volume":"31","author":"RJ Wang","year":"2014","unstructured":"Wang RJ, Lu LJ, Jin LB, Li HY, Ren GS, Wu KN, et al. Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of china. Med Oncol. 2014;31(1):788.","journal-title":"Med Oncol"},{"issue":"1","key":"4981_CR2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ijc.26341","volume":"131","author":"B Pan","year":"2012","unstructured":"Pan B, Ren H, Ma Y, Liu D, Yu B, Ji L, et al. High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells. Int J Cancer. 2012;131(1):70\u201382.","journal-title":"Int J Cancer"},{"issue":"4","key":"4981_CR3","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ijc.29440","volume":"137","author":"X Liu","year":"2015","unstructured":"Liu X, Hemminki K, Forsti A, Sundquist K, Sundquist J, Ji J. Cancer risk in patients with type 2 diabetes mellitus and their relatives. Int J Cancer. 2015;137(4):903\u201310.","journal-title":"Int J Cancer"},{"issue":"1","key":"4981_CR4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10549-014-3146-9","volume":"148","author":"J Luo","year":"2014","unstructured":"Luo J, Virnig B, Hendryx M, Wen S, Chelebowski R, Chen C, et al. Diabetes, diabetes treatment and breast cancer prognosis. Breast Cancer Res Treat. 2014;148(1):153\u201362.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"4981_CR5","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1007\/s12032-011-0109-4","volume":"29","author":"MA Kaplan","year":"2012","unstructured":"Kaplan MA, Pekkolay Z, Kucukoner M, Inal A, Urakci Z, Ertugrul H, et al. Type 2 diabetes mellitus and prognosis in early stage breast cancer women. Med Oncol. 2012;29(3):1576\u201380.","journal-title":"Med Oncol"},{"issue":"3","key":"4981_CR6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/mco.2015.522","volume":"3","author":"DE He","year":"2015","unstructured":"He DE, Bai JW, Liu J, Du CW, Huang WH, Zhang GJ. Clinicopathological characteristics and prognosis of breast cancer patients with type 2 diabetes mellitus. Mol Clin Oncol. 2015;3(3):607\u201312.","journal-title":"Mol Clin Oncol"},{"key":"4981_CR7","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1038\/cddis.2014.430","volume":"5","author":"X Li","year":"2014","unstructured":"Li X, Du N, Zhang Q, Li J, Chen X, Liu X, et al. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 2014;5:e1479.","journal-title":"Cell Death Dis"},{"issue":"10","key":"4981_CR8","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.bbamcr.2015.05.033","volume":"1853","author":"S Trehoux","year":"2015","unstructured":"Trehoux S, Lahdaoui F, Delpu Y, Renaud F, Leteurtre E, Torrisani J, et al. Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells. Biochim Biophys Acta. 2015;1853(10):2392\u2013403.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4981_CR9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ygyno.2015.01.531","volume":"137","author":"J Li","year":"2015","unstructured":"Li J, Li L, Li Z, Gong G, Chen P, Liu H, et al. The role of miR-205 in the VEGF-mediated promotion of human ovarian cancer cell invasion. Gynecol Oncol. 2015;137(1):125\u201333.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"4981_CR10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.canlet.2014.11.058","volume":"357","author":"S Kim","year":"2015","unstructured":"Kim S, Rhee JK, Yoo HJ, Lee HJ, Lee EJ, Lee JW, et al. Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer. Cancer Lett. 2015;357(2):488\u201397.","journal-title":"Cancer Lett"},{"issue":"3","key":"4981_CR11","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1167\/iovs.12-10977","volume":"54","author":"X Chen","year":"2013","unstructured":"Chen X, He D, Dong XD, Dong F, Wang J, Wang L, et al. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma. Invest Ophthalmol Vis Sci. 2013;54(3):2248\u201356.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"4981_CR12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00592-014-0675-y","volume":"52","author":"G Sebastiani","year":"2015","unstructured":"Sebastiani G, Po A, Miele E, Ventriglia G, Ceccarelli E, Bugliani M, et al. MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion. Acta Diabetol. 2015;52(3):523\u201330.","journal-title":"Acta Diabetol"},{"issue":"3","key":"4981_CR13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3892\/ol.2013.1754","volume":"7","author":"H Yu","year":"2014","unstructured":"Yu H, Lin X, Wang F, Zhang B, Wang W, Shi H, et al. Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells. Oncol Lett. 2014;7(3):799\u2013804.","journal-title":"Oncol Lett"},{"issue":"37","key":"4981_CR14","doi-asserted-by":"crossref","first-page":"31155","DOI":"10.1074\/jbc.M112.362632","volume":"287","author":"X Zhao","year":"2012","unstructured":"Zhao X, Mohan R, Ozcan S, Tang X. MicroRNA-30d induces insulin transcription factor mafa and insulin production by targeting mitogen-activated protein 4 kinase 4 (map4k4) in pancreatic beta-cells. J Biol Chem. 2012;287(37):31155\u201364.","journal-title":"J Biol Chem"},{"issue":"1","key":"4981_CR15","first-page":"56","volume":"27","author":"M PN","year":"2014","unstructured":"PN M. World medical association publishes the revised Declaration of Helsinki. Natl Med J India. 2014;27(1):56.","journal-title":"Natl Med J India"},{"key":"4981_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12902-015-0002-9","volume":"15","author":"M Lou","year":"2015","unstructured":"Lou M, Luo P, Tang R, Peng Y, Yu S, Huang W, et al. Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord. 2015;15:9.","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"4981_CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40519-014-0139-y","volume":"19","author":"L Pala","year":"2014","unstructured":"Pala L, Barbaro V, Dicembrini I, Rotella CM. The therapy of insulin resistance in other diseases besides type 2 diabetes. Eat Weight Disord. 2014;19(3):275\u201383.","journal-title":"Eat Weight Disord"},{"issue":"12","key":"4981_CR18","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1292\/jvms.13-0230","volume":"75","author":"A Okuno","year":"2013","unstructured":"Okuno A, Kaji N, Takahashi A, Nagakubo D, Ohno-Ichiki K, Shirai M, et al. Role of insulin resistance in the pathogenesis and development of type 2 diabetes in wbn\/kob-lepr(fa) rats. J Vet Med Sci. 2013;75(12):1557\u201361.","journal-title":"J Vet Med Sci"},{"issue":"4","key":"4981_CR19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MED.0b013e3283557cd5","volume":"19","author":"K Mizokami-Stout","year":"2012","unstructured":"Mizokami-Stout K, Cree-Green M, Nadeau KJ. Insulin resistance in type 2 diabetic youth. Curr Opin Endocrinol Diabetes Obes. 2012;19(4):255\u201362.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"11","key":"4981_CR20","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.metabol.2013.06.003","volume":"62","author":"A Liu","year":"2013","unstructured":"Liu A, Kushida CA, Reaven GM. Habitual shortened sleep and insulin resistance: an independent relationship in obese individuals. Metabolism. 2013;62(11):1553\u20136.","journal-title":"Metabolism"},{"issue":"2","key":"4981_CR21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7762\/cnr.2015.4.2.97","volume":"4","author":"SR Yoon","year":"2015","unstructured":"Yoon SR, Lee JH, Na GY, Seo YJ, Han S, Shin MJ, et al. Glycated hemoglobin is a better predictor than fasting glucose for cardiometabolic risk in non-diabetic Korean women. Clin Nutr Res. 2015;4(2):97\u2013103.","journal-title":"Clin Nutr Res"},{"issue":"1","key":"4981_CR22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/jdi.12241","volume":"6","author":"M Incani","year":"2015","unstructured":"Incani M, Sentinelli F, Perra L, Pani MG, Porcu M, Lenzi A, et al. Glycated hemoglobin for the diagnosis of diabetes and prediabetes: diagnostic impact on obese and lean subjects, and phenotypic characterization. J Diabetes Investig. 2015;6(1):44\u201350.","journal-title":"J Diabetes Investig"},{"issue":"7","key":"4981_CR23","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/ijc.27394","volume":"131","author":"CE Joshu","year":"2012","unstructured":"Joshu CE, Prizment AE, Dluzniewski PJ, Menke A, Folsom AR, Coresh J, et al. Glycated hemoglobin and cancer incidence and mortality in the Atherosclerosis in Communities (ARIC) study, 1990\u20132006. Int J Cancer. 2012;131(7):1667\u201377.","journal-title":"Int J Cancer"},{"issue":"7","key":"4981_CR24","volume":"9","author":"XL Li","year":"2014","unstructured":"Li XL, Li JJ, Guo YL, Zhu CG, Xu RX, Li S, et al. Relationship of glycated hemoglobin levels with myocardial injury following elective percutaneous coronary intervention in patients with type 2 diabetes mellitus. PLoS One. 2014;9(7), e101719.","journal-title":"PLoS One"},{"issue":"12","key":"4981_CR25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/jwh.2013.4375","volume":"22","author":"HI Su","year":"2013","unstructured":"Su HI, Sue LY, Flatt SW, Natarajan L, Patterson RE, Pierce JP. Endogenous estradiol is not associated with poor physical health in postmenopausal breast cancer survivors. J Womens Health (Larchmt). 2013;22(12):1043\u20138.","journal-title":"J Womens Health (Larchmt)"},{"key":"4981_CR26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/1471-2407-13-503","volume":"13","author":"JY Kim","year":"2013","unstructured":"Kim JY, Han W, Moon HG, Ahn SK, Kim J, Lee JW, et al. Prognostic effect of preoperative serum estradiol level in postmenopausal breast cancer. BMC Cancer. 2013;13:503.","journal-title":"BMC Cancer"},{"issue":"11","key":"4981_CR27","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1634\/theoncologist.2014-0306","volume":"19","author":"P Chalasani","year":"2014","unstructured":"Chalasani P, Stopeck A, Clarke K, Livingston R. A pilot study of estradiol followed by exemestane for reversing endocrine resistance in postmenopausal women with hormone receptor-positive metastatic breast cancer. Oncologist. 2014;19(11):1127\u20138.","journal-title":"Oncologist"},{"issue":"5","key":"4981_CR28","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1007\/s13277-013-1530-4","volume":"35","author":"R Ben Gacem","year":"2014","unstructured":"Ben Gacem R, Ben Abdelkrim O, Ziadi S, Ben Dhiab M, Trimeche M. Methylation of miR-124a-1, miR-124a-2, and miR-124a-3 genes correlates with aggressive and advanced breast cancer disease. Tumour Biol. 2014;35(5):4047\u201356.","journal-title":"Tumour Biol"},{"issue":"11","key":"4981_CR29","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.18632\/oncotarget.696","volume":"3","author":"N Kobayashi","year":"2012","unstructured":"Kobayashi N, Uemura H, Nagahama K, Okudela K, Furuya M, Ino Y, et al. Identification of miR-30d as a novel prognostic maker of prostate cancer. Oncotarget. 2012;3(11):1455\u201371.","journal-title":"Oncotarget"},{"issue":"9","key":"4981_CR30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1055\/s-0032-1311644","volume":"120","author":"HY Ling","year":"2012","unstructured":"Ling HY, Hu B, Hu XB, Zhong J, Feng SD, Qin L, et al. MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3t3-l1 adipocytes through targeting phosphatase and tensin homologue. Exp Clin Endocrinol Diabetes. 2012;120(9):553\u20139.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"4981_CR31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","volume":"17","author":"Q Mao","year":"2015","unstructured":"Mao Q, Unadkat JD. Role of the breast cancer resistance protein (bcrp\/abcg2) in drug transport\u2014an update. AAPS J. 2015;17(1):65\u201382.","journal-title":"AAPS J"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-4981-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-016-4981-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-4981-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-016-4981-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T16:53:17Z","timestamp":1567615997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-016-4981-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,20]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["4981"],"URL":"https:\/\/doi.org\/10.1007\/s13277-016-4981-6","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,20]]}}}